Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?
| Autor: | Valent, Peter1 peter.valent@meduniwien.ac.at |
|---|---|
| Zdroj: | European Journal of Clinical Investigation. Oct2010, Vol. 40 Issue 10, p918-931. 14p. 4 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|